Acute Respiratory Distress Syndrome (ARDS) Clinical Trials

Find Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Near You

Incidence and Evolution of Heart-lung Interaction in Acute Respiratory Distress Syndrome: the IVOLIA Study

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Acute respiratory distress syndrome (ARDS) is an inflammatory injury of the lungs caused by various serious illnesses, such as a bacterial or viral lung infection. It is treated by artificial ventilation with the application of positive pressure. Pulmonary injury, coupled with artificial ventilation, can lead to right heart failure which hinders the ejection of blood to the pulmonary circulation. Modern mechanical ventilation modalities have reduced the frequency (incidence) of this right heart failure in acute respiratory distress syndrome. A large-scale study has shown this a few years ago. However, the evolution of right heart failure during artificial ventilation, and the consequences it has on the patient's cardiovascular status are poorly determined. This study is conducted to improve knowledge in this area. In adult patients hospitalized in intensive care presenting acute respiratory distress syndrome, the investigators will collect the data recorded on cardiac ultrasound, doses of cardiovascular drugs as well as variables reflecting hemodynamic status and cell oxygenation. Data will be collected during the course of ARDS and mechanical ventilation, as well as after weaning from artificial ventilation.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥18 years old

• Hospitalization in intensive care undergoing mechanical ventilation

• Presence of ARDS according to the current consensus definition (Berlin definition)

• Performance of at least one echocardiography during the first 24 hours of treatment, between the 2nd and 3rd day, between the 5th and 7th day, and within 48 hours of extubation

Locations
Other Locations
France
Chu de Bicêtre, AP-HP
RECRUITING
Le Kremlin-bicêtre
Contact Information
Primary
Xavier Monnet, MD, PhD
xavier.monnet@aphp.fr
+33-(0)6660862669
Backup
Christopher Lai, MD, PhD
christopher.lai@aphp.fr
+33145212671
Time Frame
Start Date: 2022-12-22
Estimated Completion Date: 2028-01
Participants
Target number of participants: 500
Treatments
Patients with ARDS under mechanical ventilation
* Age ≥18 years old~* Hospitalization in intensive care~* Presence of ARDS according to the current consensus definition
Sponsors
Leads: Bicetre Hospital
Collaborators: Hôpital Cochin, Humanitas Hospital, Italy, Henri Mondor University Hospital, Tenon Hospital, Paris

This content was sourced from clinicaltrials.gov